CARLSBAD, Calif., — Life Technologies Corporation (NASDAQ: LIFE) today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its 3500 Dx Genetic Analyzers and SeCore® HLA typing kits. The development represents additional execution against the company’s strategy to become a leader in the diagnostics market by offering both novel clinical […]
SANTA CLARA, Calif. — Affymetrix, Inc. (NASDAQ: AFFX) and DNA Link, Inc., a Korean genomics-based biotechnology company, today announced that they have signed a Powered by AffymetrixTM (PbA) Program agreement in which DNA Link, Inc. obtains a worldwide license to develop and commercialize a forensic test for comprehensive human identification and other diagnostic tests using […]
Frederick, MD —— Akonni Biosystems, a developer of nucleic acid extraction products that are 2-fold to 5-fold faster than industry gold standards, and low-cost mid-multiplex platforms for genetic testing, announced today that the United States Patent and Trademark Office issued two patents for its novel method for amplifying nucleic acids using polymerase chain reaction (PCR). […]
SAN DIEGO, – Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, announced today that the MaterniT21™ PLUS laboratory-developed test (LDT) available exclusively through Sequenom Center for Molecular Medicine (Sequenom CMM) will now report as additional findings the presence of certain fetal sex chromosomal aneuploidies, in addition to […]
Chalfont St. Giles, UKv: GE Healthcare’s work to accelerate cancer innovation and improve care for cancer patients reached new milestones in advanced technology. The campaign is founded on GE Healthcare’s integrated portfolio, which is uniquely positioned to drive impact in oncology and a leap forward for individualized cancer care. GE Healthcare launched a series of […]
HILDEN, Germany, and GERMANTOWN, Maryland, — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that Clarient – a GE Healthcare Company and leading provider of cancer laboratory testing services in the United States – has adopted the use of the therascreen® KRAS RGQ PCR Kit (therascreen KRAS test) as a companion diagnostic to […]
Lexington, MA, – T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the U.S. Patent and Trademark Office has issued two design patents covering components of the T2Dx direct detection device. These patents, USD673,293 and USD674,112, describe cartridge designs for the Company’s T2Candida assay, which is run on the T2Dx platform. […]
CARLSBAD, Calif., — Life Technologies Corporation (NASDAQ: LIFE) today announced the establishment of the Global Influenza Network, a partnership including scientists at a number of the world’s leading government public health organizations, veterinary agencies and research institutes in a collaborative effort to increase the speed and efficiency of influenza monitoring and vaccine development. Members of […]
Paris, – Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities, and GenoSplice Technology, developers of bioinformatics solutions for analysis of genomic data, today announce they have formed a partnership to combine their expertise. This collaboration will provide GenoSplice with access to several Curie-Cancer technology platforms to allow it to continue to improve […]
Palo Alto, CA — Syapse, the leader in bringing omics into routine medical use, announced unprecedented momentum in helping laboratories and clinics generate and use next-generation sequencing to diagnose and treat patients. Syapse software is now involved in the processing of over 3,000 patient genomes and thousands of transcriptome, proteome, immunome, and microbiome profiles per […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
